A phase IIa efficacy and safety trial with intravenous S95011 in primary SjÃ¶gren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study

Short title	A phase IIa efficacy and safety trial with intravenous S95011 in primary SjÃ¶gren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study
Status	Finished
Effective start/end date	1/03/21 → 28/02/22

Project Details